Helen of Troy (NASDAQ:HELE) Downgraded by Zacks Research to Hold

Helen of Troy (NASDAQ:HELE) was downgraded by Zacks Research from a “strong-buy” rating to a “hold” rating in a report issued on Monday,Zacks.com reports.

Other analysts have also recently issued research reports about the company. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Helen of Troy in a research report on Wednesday, June 24th. Canaccord Genuity Group upped their price target on Helen of Troy from $18.00 to $23.00 and gave the company a “hold” rating in a research report on Friday, April 24th. UBS Group increased their price objective on Helen of Troy from $16.00 to $25.00 and gave the stock a “neutral” rating in a research note on Friday, April 24th. Finally, Wall Street Zen cut Helen of Troy from a “buy” rating to a “hold” rating in a research note on Saturday, May 23rd. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Helen of Troy presently has a consensus rating of “Hold” and a consensus target price of $24.00.

Helen of Troy Stock Up 1.9%

HELE stock opened at $28.04 on Monday. Helen of Troy has a 52-week low of $13.85 and a 52-week high of $31.98. The company’s 50 day simple moving average is $26.12 and its 200-day simple moving average is $20.82. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.71 and a quick ratio of 0.81. The firm has a market capitalization of $653.05 million, a P/E ratio of -0.72 and a beta of 1.31.

Helen of Troy (NASDAQ:HELE) last posted its quarterly earnings data on Thursday, April 23rd. The company reported $0.83 EPS for the quarter, topping analysts’ consensus estimates of $0.74 by $0.09. Helen of Troy had a negative net margin of 50.33% and a positive return on equity of 7.00%. The firm had revenue of $470.03 million during the quarter, compared to analyst estimates of $450.38 million. During the same quarter last year, the business posted $2.33 EPS. The company’s revenue was down 3.3% on a year-over-year basis. Helen of Troy has set its FY 2027 guidance at 3.250-3.750 EPS. As a group, equities research analysts anticipate that Helen of Troy will post 2.81 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of HELE. Invenomic Capital Management LP increased its stake in shares of Helen of Troy by 68.8% during the 3rd quarter. Invenomic Capital Management LP now owns 554,985 shares of the company’s stock worth $13,986,000 after purchasing an additional 226,263 shares during the last quarter. Seven Six Capital Management LLC bought a new stake in Helen of Troy in the third quarter worth $1,378,000. Prescott Group Capital Management L.L.C. acquired a new position in Helen of Troy during the fourth quarter worth $2,344,000. Aster Capital Management DIFC Ltd acquired a new position in Helen of Troy during the fourth quarter worth $504,000. Finally, UBS Group AG raised its holdings in Helen of Troy by 386.0% during the fourth quarter. UBS Group AG now owns 616,992 shares of the company’s stock valued at $13,111,000 after buying an additional 490,031 shares in the last quarter.

Helen of Troy News Summary

Here are the key news stories impacting Helen of Troy this week:

• Positive Sentiment: Canaccord Genuity kept a Hold rating on Helen of Troy and left its $23 price target unchanged, suggesting the analyst sees the current setup as mixed but not deteriorating further. Article Title
• Positive Sentiment: Zacks highlighted Helen of Troy as a “Fast-Paced Momentum at a Bargain” stock, reinforcing the idea that recent trading strength may still have room to continue if investors focus on valuation and momentum. Article Title
• Neutral Sentiment: Several entertainment articles about “Helen of Troy” and “The Odyssey” surfaced, but they are unrelated to Helen of Troy Limited’s business and are unlikely to affect HELE shares.
• Negative Sentiment: Multiple law firms issued investor alerts about a class-action lawsuit against Helen of Troy Limited, with deadlines approaching for investors who may have suffered losses. That legal overhang can weigh on sentiment and raise uncertainty around the stock. Article Title

About Helen of Troy

Helen of Troy Limited is a global consumer products company that designs, sources and markets a diversified portfolio of household, health and beauty brands. Headquartered in El Paso, Texas, the company operates through three principal segments—Health & Home, Housewares and Beauty—offering products under well-known names including OXO, Vicks, Braun, Honeywell Home, PUR and Hot Tools. Helen of Troy distributes its products through a combination of mass, specialty and e-commerce channels to consumers, retailers and distributors worldwide.

The Housewares segment features kitchen tools, gadgets and organizational solutions marketed primarily under the OXO brand, recognized for its ergonomic “Good Grips” design.